HINJ Article: Artificial Intelligence is Accelerating the Life Sciences’ Quest for New Treatments and Cures
Two articles by HINJ featured in New Jersey Business Magazine’s June Innovation Edition. New Jersey positioned to be a global leader as artificial intelligence revolutionizes medical innovation by HINJ CEO Chrissy Buteas Saving lives globally while finding cures in New Jersey by HINJ CEO Chrissy Buteas The full June edition (“34th Annual Innovative State”) can […]
Op-Ed: New Jersey’s Life Sciences: Keeping the World Healthy for 150 Years
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) May 28, 2025 – As America prepares to celebrate our 250th anniversary, it’s worth reminding ourselves that New Jersey has been known as the “Crossroads of the Revolution” since our nation’s founding. From Washington’s daring Delaware River crossing to surprise British and […]
HealthCare Institute of New Jersey Statement on Make America Healthy Again Report
Trenton, May 22, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, issued the following statement concerning today’s release of the Make America Healthy Again report: “The sole mission of New Jersey’s life sciences is to help American patients and those around the world live longer, with greater […]
Op-Ed: ‘Most Favored Nation’ Proposal Won’t Favor American Patients or New Jersey Jobs
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) A new threat has suddenly emerged for American patients and New Jersey’s economy. A proposal called “Most Favored Nation” (MFN) is being discussed by some policymakers in Washington. While the intended goal is admirable – to lower healthcare costs – the actual […]
HealthCare Institute of New Jersey Statement on White House “Most Favored Nation” Executive Order
Trenton, May 12, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning today’s White House Executive Order on the “Most Favored Nation” drug pricing action: “This ‘most favored nation’ (MFN) proposal won’t favor American patients or New Jersey jobs. This idea takes parts […]
HINJ Comment Submission for Section 232 Investigation on Pharmaceutical Tariffs
Trenton, May 12, 2025 ― HINJ submitted comments to the Department of Commerce as per the Federal Register’s Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients. These comments were filed in opposition to potential tariffs on pharmaceutical products and were broadly written to convey […]
HealthCare Institute of New Jersey Statement on Biomarker Testing Law
Trenton, April 23, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ), released the following statement concerning today’s signing into law of the state legislature’s biomarker testing bill, A4163/S3098, by Lieutenant Governor Tahesha Way. “New Jersey’s life sciences community applauds today’s enactment of this important legislation, which […]
Op-Ed: Celebrating STEM Month: New Jersey is Based on Science
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) America is a kaleidoscope of incredible cities and states, each with its unique flavor and identity. The beauty and dry heat of Arizona, along with the magnificent Grand Canyon; beignets and coffee on a humid morning in New Orleans; the breathtaking Big […]
We Need Experts to Protect Patients and NJ Manufacturing
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) February 15, 2025 – Last year, Gov. Phil Murphy and the New Jersey Legislature launched a new initiative intended to lower the cost of medicines for New Jersey patients – the Prescription Drug Affordability Council (PDAC). The Council, with members appointed by […]
HealthCare Institute of New Jersey Submits Comments on PDAC Special Rule Adoption
Trenton, January 21, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning comments HINJ submitted to the NJ Division of Consumer Affairs’ concerning its proposed rules currently in effect and being considered for formal adoption relating to prescription drug price transparency and the […]